Lallemand Health Solutions’ R&D Director for Microbiome Program and Bioprocess and Galenic Center, Sylvie Binda, together with IPA colleagues have cowritten a…
Thomas A. Tompkins, Ph.D., Research Director at the Rosell® Institute from Microbiome and Probiotics by Lallemand, is proud to be joining the…
Lallemand Health Solutions and Nimble Science are proud to officially kick-off the first North American clinical study of Nimble’ Small Intestine Microbiome…
Lallemand Health Solutions and the Natural Health Product Research Alliance (NHP RA) affiliated with the University of Guelph, both Canadian entities, are…
Make the difference and expand the synergistic effect of S. boulardii by combining the probiotic yeast with powerful yeast-based ingredients and documented…
Discover the latest open access review on “The effects of psychobiotics on the microbiota-gut-brain axis in early-life stress and neuropsychiatric disorders” recently…
Lallemand Health Solutions has gained new indications for its documented Expert’Biotic IBacilluS+ (a combination of probiotic strain Enterococcus faecium Rosell®-26 and Bacillus…
Infantile stress predisposes individuals to higher anxiety in adulthood. In a new in vivo study, early intake of Lacidofil® (Lallemand Health Solutions…
A new post-hoc analysis confirmed in humans that CEREBIOME® can increase significantly brain-derived neurotrophic factor (BDNF) serum levels as observed several years…
Apsen, located in São Paulo, Brazil, in partnership with Lallemand Health Solutions, are launching in September the first probiotic formulation for the…
